Alnylam Pharmaceuticals Aktie
263,70
EUR
-6,00
EUR
-2,22
%
307,94
USD
-4,35
USD
-1,39
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung